FDA panel backs low-dose Pfizer vaccines for children
A Food and Drug Administration (FDA) panel voted unanimously, with one abstention, Oct. 26 to endorse kid-size doses of the Pfizer COVID-19 vaccine for children 5- to 11-years-old.…
A Food and Drug Administration (FDA) panel voted unanimously, with one abstention, Oct. 26 to endorse kid-size doses of the Pfizer COVID-19 vaccine for children 5- to 11-years-old.…